Status: current, Defined. Date: 31-Mar 2016. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1558531000168117 | cobicistat 150 mg + elvitegravir 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
1558541000168114 | tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | Is a | cobicistat 150 mg tablet | true | Inferred relationship | Some | ||
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | Is a | tenofovir + emtricitabine + elvitegravir + cobicistat | false | Inferred relationship | Some | ||
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | Is a | medicinal product unit of use | false | Inferred relationship | Some | ||
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1452675827 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has Australian BoSS | tenofovir alafenamide | false | Inferred relationship | Some | 1104167331 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has intended active ingredient | tenofovir | false | Inferred relationship | Some | 1104167331 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has intended active ingredient | cobicistat | true | Inferred relationship | Some | 1452675826 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has Australian BoSS | cobicistat | true | Inferred relationship | Some | 1452675826 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has Australian BoSS | emtricitabine | true | Inferred relationship | Some | 1353536634 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has intended active ingredient | emtricitabine | true | Inferred relationship | Some | 1353536634 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has Australian BoSS | elvitegravir | true | Inferred relationship | Some | 1348968074 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has intended active ingredient | elvitegravir | true | Inferred relationship | Some | 1348968074 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | Is a | tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat | true | Inferred relationship | Some | ||
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has intended active ingredient | tenofovir alafenamide | true | Inferred relationship | Some | 577076222 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | has Australian BoSS | tenofovir alafenamide | true | Inferred relationship | Some | 577076222 | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | Is a | emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Genvoya tablet | Is a | True | tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | Inferred relationship | Some | |
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 | has MPUU | True | tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product unit of use reference set